NeuroRelax

product on market Capsule Karuna Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula combines passion flower, California poppy, and jujube, which have moderate evidence for promoting relaxation and sleep. St. John's Wort and DL-Phenylalanine are studied for mood support, though overall evidence coverage for this specific blend is limited. The ingredient profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for NeuroRelax
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

DL-Phenylalanine
500 mg
Market median: 300.0mg (240 products) 20 studies — no high-quality reviews
Jujube
200 mg
California Poppy
200 mg
Passion flower
200 mg
Skullcap
200 mg
150 mg
Market median: 300.0mg (122 products) 22 studies (A:0, B:7)

Other Ingredients

Vegetarian Capsule Cellulose Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use for adults: Two capsules twice daily, away from meals, or as directed by your health care practitioner.

Warnings & Precautions

Warning: Do not use if pregnant, or with MAO inhibitors. If you are pregnant, trying to become pregnant, nursing, or taking any drugs or medications consult your physician before taking. St. John's Wort may cause undesirable reactions when combined with certain drugs or prescription medications.

Notice: Avoid excessive exposure to UV irradiation (e.g., sunlight; tanning) when using this product.

Formulation Notes

Herbal Concentrate with DL-Phenylalanine

Additional Information

KARUNA(R) RESPONSIBLE NUTRITION(TM)

Keep in a cool, dry place, tightly capped.

5125-lb4

Metadata

Product Details

DSLD Entry Date2013-08-23
Product TypeOther Combinations
FormCapsule
BrandKaruna
DSLD ID24763
Data Updated2026-04-11
Research

Research Evidence

43
Research Sources
48
Avg Quality
16
Meta Analysis
14
Systematic Review
7
Rct
4
Regulatory Source
1
Clinical Trial
1
Openfda Safety
B St John's wort for major depression
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
B Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
Meta Analysis Journal of affective disorders 2017 PubMed DOI
B A systematic review of St. John's wort for major depressive disorder
Meta Analysis Systematic reviews 2016 PubMed DOI
B St John's wort for depression
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis
Meta Analysis Neuropsychopharmacology reports 2025 PubMed DOI
B St John's wort for depression
Meta Analysis The Cochrane database of systematic reviews 2005 PubMed
C St John's wort for depression: meta-analysis of randomised controlled trials
Meta Analysis The British journal of psychiatry : the journal of mental science 2005 PubMed
C The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial
Rct Complementary therapies in medicine 2019 PubMed DOI
C Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks
Rct BMJ (Clinical research ed.) 1999 PubMed
C Hypericum perforatum as a cognitive enhancer in rodents: A meta-analysis
Meta Analysis Scientific reports 2016 PubMed DOI
View all evidence for St Johns Wort →
Compare

Similar Products

View all St Johns Wort products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.